证券时报·数据宝统计，截至今日下午收盘，上证综指3889.50点，收于五日均线之下，涨跌幅-0.19%， A股总成交额为23742.21亿元。到目前为止，今日有284只A股价格突破了五日均线，其中乖离率较大的 个股有银河磁体、江丰电子、金银河等，乖离率分别为14.40%、9.00%、8.31%；广立微、港通医疗、 派瑞股份等个股乖离率较小，刚刚站上五日均线。 10月13日突破五日均线个股乖离率排名 | 证券代 | 证券简 | 今日涨跌幅 | 今日换手率 | 五日均线 | 最新价 | 乖离率 | | --- | --- | --- | --- | --- | --- | --- | | 码 | 称 | （%） | （%） | （元） | （元） | （%） | | 300127 | 银河磁 体 | 20.01 | 16.89 | 33.86 | 38.74 | 14.40 | | 300666 | 江丰电 子 | 14.54 | 20.46 | 105.07 | 114.52 | 9.00 | | 300619 | 金银河 | 12.35 | 15.45 | 34.78 | 37.67 | 8.31 | | 6 ...

格隆汇10月9日丨港通医疗(301515.SZ)公布，截至2025年9月30日，公司通过股票回购专用证券账户以 集中竞价交易方式回购股份，累计回购股份数量为2,858,786股，占公司总股本的2.86%，其中最高成交 价为19.68元/股，最低成交价为16.57元/股，成交总金额为53,046,196.79元（不含交易费用）。本次回购 符合相关法律法规及公司既定回购股份方案的要求。 ...

证券代码：301515 证券简称：港通医疗 公告编号：2025-057 四川港通医疗设备集团股份有限公司 关于2024年第二次回购公司股份进展的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 四川港通医疗设备集团股份有限公司（以下简称"公司"）于 2024 年 11 月 4 日召开第四届董事会第十七次会议和第四届监事会第十七次会议，审议通过 《关于 2024 年第二次回购公司股份方案的议案》，公司拟使用不低于人民币 5,000 万元（含）且不超过人民币 10,000 万元（含）的自有资金和专项回购贷款 资金以集中竞价交易的方式回购公司已发行的人民币普通股（A 股）股票，回购 价格不超过人民币 28.49 元/股（含），回购的股份将用于实施员工持股计划或 股权激励。本次回购股份的实施期限为自公司董事会审议通过本次回购股份方案 之日起不超过 12 个月。具体回购股份的数量以回购期满或回购完毕时公司实际 回购的股份数量为准。 公司于 2024 年 11 月 8 日召开 2024 年第一次临时股东会，审议通过《关于 公司 2024 年前三季度利润分配预案的议案》 ...

南财智讯9月25日电，港通医疗公告，AresCorporateOpportunitiesFundAsia,L.P.将其持有的开曼GT100% 股权转让给EverThrive，导致Ares不再控制公司5%以上股东香港GT。此次权益变动前，Ares通过开曼 GT和香港GT间接持有公司11.50%股权；变动后，Ares不再持有公司股份。EverThrive通过开曼GT和香 港GT间接持有公司11.50%股权。Ares在未来12个月内无增持或减持计划。 ...

证券代码：301515 证券简称：港通医疗 公告编号：2025-056 2025年9月24日，四川港通医疗设备集团股份有限公司（以下简称"公司"、 "港通医疗"）收到持股5%以上股东GT South (Hong Kong) Limited（以下简称 "香港GT"）的通知，其上层股东GT North (Cayman) Ltd.，（以下简称"开曼 GT"）的上层股东Ares Corporate Oppotunities Fund Asia, L.P.（以下简称 "Ares"）与Ever Thrive Global Limited（以下简称"Ever Thrive"）共同 签署了《股权收购协议》，Ever Thrive受让Ares持有的开曼GT100%股权。Ares、 Ever Thrive已履行权益变动报告义务，具体内容详见同日披露于巨潮资讯网 （http://www.cninfo.com.cn）的《简式权益变动报告书》（Ares）、《简式权 益变动报告书》（Ever Thrive）。 本次股权转让前，Ares通过开曼GT和香港GT间接持有公司11.50%股权（Ares 持有开曼GT 100%股权；开曼GT持有香 ...

四川港通医疗设备集团股份有限公司 简式权益变动报告书 签署日期： 2025 年9 月24日 信息披露义务人声明 一、信息披露义务人依据《中华人民共和国证券法》（以下简称"《证券法》"） 《上市公司收购管理办法》（以下简称"《收购办法》"）《公开发行证券的公司信息披 露内容与格式准则第15 号——权益变动报告书》等相关法律、法规、规范性文件的规 定编写本报告书。 二、信息披露义务人签署本报告已获得必要的授权和批准。 三、依据《证券法》和《收购办法》的规定，本报告书已全面披露信息披露义务 人在四川港通医疗设备集团股份有限公司（以下简称"港通医疗"）拥有权益的股 份变动情况。截至本报告书签署之日，除本报告书披露的信息外，上述信息披露义务 人没有通过任何其他方式增加或减少其在港通医疗中拥有权益的股份。 四、本次权益变动是根据本报告书所载明的资料进行的。除信息披露义务人之外， 没有委托或者授权任何其他人提供未在本报告书中列载的信息和对本报告书作出任何解 释或者说明。 五、信息披露义务人承诺本报告书不存在虚假记载、误导性陈述或重大遗漏，并对其 真实性、准确性、完整性承担个别和连带的法律责任。 2 上市公司名称：四川港通医 ...

四川港通医疗设备集团股份有限公司 简式权益变动报告书 上市公司的名称：四川港通医疗设备集团股份有限公司 股票上市地点：深圳证券交易所 股票简称：港通医疗 股票代码：301515 信息披露义务人的名称：Ever Thrive Global Limited 住所/通讯地址：Vistra Corporate Services Centre, Wickhams Cay II, Road Town, Tortola, VG1110, British Virgin Islands 股份变动性质：间接持有股份增加 签署日期：2025 年 9 月 24 日 1 四、本次权益变动是根据本报告书所载明的资料进行的。除信息披露义务人 外，没有委托或者授权任何其他人提供未在本报告书中列载的信息和对本报告书 做出任何解释或者说明。 五、信息披露义务人承诺本报告不存在虚假记载、误导性陈述或重大遗漏， 并对其真实性、准确性和完整性承担个别和连带的法律责任。 2 | | | 信息披露义务人声明 一、信息披露义务人根据《中华人民共和国证券法》（以下简称"《证券法》"） 《上市公司收购管理办法》（以下简称"《收购办法》"）《公开发行证券的公司信 ...

Core Viewpoint - The company, 港通医疗, is experiencing a decline in stock performance and has reported significant decreases in revenue and net profit for the first half of 2023, indicating potential challenges ahead [8]. Company Overview - 港通医疗, established on January 13, 1998, is located in Chengdu, Sichuan Province, and was listed on July 25, 2023. The company specializes in providing medical gas systems and clean operating room solutions for medical institutions [7]. - The company's main business revenue composition includes: 55.69% from clean medical equipment and systems, 37.30% from medical gas equipment and systems, 4.06% from medical device sales, 2.81% from operation and maintenance services, and 0.14% from other sources [8]. Financial Performance - For the first half of 2023, 港通医疗 reported revenue of 265 million yuan, a year-on-year decrease of 39.29%, and a net profit attributable to shareholders of -8.4044 million yuan, a year-on-year decrease of 154.53% [8]. - The company has cumulatively distributed 48.9973 million yuan in dividends since its A-share listing [9]. Market Activity - On September 23, 港通医疗's stock fell by 1.99%, with a trading volume of 35.9516 million yuan and a turnover rate of 2.80%, resulting in a total market capitalization of 2.073 billion yuan [1]. - The stock has seen a net outflow of 270,100 yuan from major investors today, with a continuous reduction in major funds over the past three days [4][5]. Strategic Developments - 港通医疗 has developed the 港通云监测平台, which utilizes advanced IoT technology for real-time monitoring of medical equipment in hospitals [3]. - The company plans to repurchase shares with a total fund of no less than 50 million yuan and no more than 100 million yuan, with a maximum price of 28.49 yuan per share, funded by its own resources and a special loan from Bank of China [3]. Industry Position - 港通医疗 has been recognized as a "specialized, refined, distinctive, and innovative" small giant enterprise, which is a prestigious title for small and medium-sized enterprises in China, indicating its strong market position and innovation capabilities [3].

Market Overview - The Shanghai Composite Index closed at 3781.61 points, with a decline of 1.23% [1] - The total trading volume of A-shares reached 1713.539 billion yuan [1] Technical Analysis - A total of 228 A-shares experienced a death cross, where the 5-day moving average fell below the 10-day moving average [1] - Notable stocks with significant distance between their 5-day and 10-day moving averages include: - Innovation Medical: 5-day MA at 22.55 yuan, 10-day MA at 23.23 yuan, a difference of -2.92% [1] - North Long Dragon: 5-day MA at 121.67 yuan, 10-day MA at 123.65 yuan, a difference of -1.60% [1] - Xiangyu Medical: 5-day MA at 54.49 yuan, 10-day MA at 55.34 yuan, a difference of -1.53% [1] Individual Stock Performance - Significant declines in stock prices include: - Innovation Medical: down 4.27% with a turnover rate of 14.36% [1] - North Long Dragon: down 4.52% with a turnover rate of 13.85% [1] - Xiangyu Medical: down 5.86% with a turnover rate of 1.42% [1] - Other notable declines: - Shandong Mining Machine: down 4.43% [1] - Huakang Clean: down 6.50% [1] - Beautiful Ecology: down 5.15% [1] Additional Stock Data - The following stocks also showed significant declines: - Yuyin Co.: down 5.46% [2] - Kexin Information: down 5.22% [1] - Visual China: down 3.88% [1] - Stocks with notable trading activity include: - Hengbao: down 6.64% with a turnover rate of 10.88% [2] - Changbai Mountain: down 6.53% with a turnover rate of 4.05% [2]

Core Viewpoint - The company, 港通医疗, is experiencing fluctuations in stock performance and has recently announced a share buyback plan while also highlighting its achievements in the medical device sector [1][3]. Company Overview - 港通医疗, established on January 13, 1998, is located in Chengdu, Sichuan Province, and specializes in providing medical gas systems and clean operating room solutions for healthcare institutions [7]. - The company's main business revenue composition includes: 55.69% from medical clean equipment and systems, 37.30% from medical gas equipment and systems, 4.06% from medical device sales, 2.81% from operation and maintenance services, and 0.14% from other sources [8]. Financial Performance - For the first half of 2023, 港通医疗 reported revenue of 265 million yuan, a year-on-year decrease of 39.29%, and a net profit attributable to shareholders of -8.4044 million yuan, a year-on-year decrease of 154.53% [8]. - The company has distributed a total of 48.9973 million yuan in dividends since its A-share listing [9]. Recent Developments - 港通医疗 has developed the 港通云监测平台, which utilizes advanced IoT and cloud monitoring technologies to provide real-time monitoring solutions for medical equipment [3]. - The company plans to repurchase shares with a total fund of no less than 50 million yuan and no more than 100 million yuan, with a maximum price of 28.49 yuan per share, funded by its own resources and a special loan from Bank of China [3]. Market Position - 港通医疗 has been recognized as a "specialized, refined, distinctive, and innovative" small giant enterprise, indicating its strong market position and innovation capabilities [3]. - The company is part of the medical device industry, specifically in the medical equipment sector, and is categorized under various concepts including micro-cap stocks and specialized small enterprises [8]. Trading Activity - On September 22, 港通医疗's stock fell by 1.03%, with a trading volume of 17.2185 million yuan and a turnover rate of 1.29%, resulting in a total market capitalization of 2.115 billion yuan [1]. - The stock has seen a net outflow of 198,700 yuan from major investors, indicating a trend of reduced holdings over the past three days [4][5].